These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 20376860)
1. Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP. Latorre-Esteves E; Akilov OE; Rai P; Beverley SM; Hasan T J Biophotonics; 2010 Jun; 3(5-6):328-35. PubMed ID: 20376860 [TBL] [Abstract][Full Text] [Related]
2. Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Akilov OE; Kosaka S; O'Riordan K; Hasan T Exp Dermatol; 2007 Aug; 16(8):651-60. PubMed ID: 17620092 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation. Akilov OE; Kosaka S; O'Riordan K; Hasan T Photochem Photobiol Sci; 2007 Oct; 6(10):1067-75. PubMed ID: 17914480 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of photodynamic therapy using TiO Sepúlveda AAL; Arenas Velásquez AM; Patiño Linares IA; de Almeida L; Fontana CR; Garcia C; Graminha MAS Photodiagnosis Photodyn Ther; 2020 Jun; 30():101676. PubMed ID: 32001331 [TBL] [Abstract][Full Text] [Related]
5. Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis. Akilov OE; Yousaf W; Lukjan SX; Verma S; Hasan T Lasers Surg Med; 2009 Jul; 41(5):358-65. PubMed ID: 19533767 [TBL] [Abstract][Full Text] [Related]
6. Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis. Calvo-Álvarez E; Guerrero NA; Alvarez-Velilla R; Prada CF; Requena JM; Punzón C; Llamas MÁ; Arévalo FJ; Rivas L; Fresno M; Pérez-Pertejo Y; Balaña-Fouce R; Reguera RM PLoS Negl Trop Dis; 2012; 6(11):e1927. PubMed ID: 23209866 [TBL] [Abstract][Full Text] [Related]
7. Analysis of Macrophage Activation Markers in an Experimental Model of Cutaneous Leishmaniasis Treated with Photodynamic Therapy Mediated by 5-Aminolevulinic Acid. Silva MLF; Alves PM; Souza DM; Silva MV; Dos Santos JP; Paulino TP; Rodrigues DB; Rodrigues V Photobiomodul Photomed Laser Surg; 2019 May; 37(5):298-304. PubMed ID: 31084559 [No Abstract] [Full Text] [Related]
8. Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice. Ribeiro JBP; Miranda-Vilela AL; Graziani D; Gomes MRA; Amorim AAS; Garcia RD; de Souza Filho J; Tedesco AC; Primo FL; Moreira JR; Lima AV; Sampaio RNR Photodiagnosis Photodyn Ther; 2016 Mar; 13():282-290. PubMed ID: 26306406 [TBL] [Abstract][Full Text] [Related]
9. Study of the efficacy of N-methyl glucamine antimoniate (Sb Ribeiro JBP; Miranda-Vilela AL; Amorim AAS; Garcia RD; Moreira JR; Gomes CM; Takano GHS; de Oliveira GMF; Lima AV; da Silva ICR; Sampaio RNR Photodiagnosis Photodyn Ther; 2019 Jun; 26():261-269. PubMed ID: 30951865 [TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of Old World cutaneous leishmaniasis with red or green light photodynamic therapy]. Burmann SN; Oellig F; Paschos A; Hofmann SC; Lehmann P; Kreuter A; Balakirski G Dermatologie (Heidelb); 2022 Dec; 73(12):952-958. PubMed ID: 35951076 [TBL] [Abstract][Full Text] [Related]
11. Treatment of cutaneous leishmaniasis by photodynamic therapy. Gardlo K; Horska Z; Enk CD; Rauch L; Megahed M; Ruzicka T; Fritsch C J Am Acad Dermatol; 2003 Jun; 48(6):893-6. PubMed ID: 12789181 [TBL] [Abstract][Full Text] [Related]
12. Topical photodynamic therapy with chloroaluminum phthalocyanine liposomes is as effective as systemic pentavalent antimony in the treatment of experimental cutaneous leishmaniasis. Lopes SC; Silva RA; Novais MV; Coelho LD; Ferreira LA; Souza PE; Tedesco A; Azevedo RB; Aguiar MG; Oliveira MC Photodiagnosis Photodyn Ther; 2019 Dec; 28():210-215. PubMed ID: 31454712 [TBL] [Abstract][Full Text] [Related]
13. The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites. Akilov OE; Kosaka S; O'Riordan K; Song X; Sherwood M; Flotte TJ; Foley JW; Hasan T Chem Biol; 2006 Aug; 13(8):839-47. PubMed ID: 16931333 [TBL] [Abstract][Full Text] [Related]
14. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions. Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476 [TBL] [Abstract][Full Text] [Related]
15. Daylight photodynamic therapy for cutaneous leishmaniasis in a pediatric setting: A case report and literature review. Li Pomi F; Peterle L; Vaccaro M; Borgia F Photodiagnosis Photodyn Ther; 2023 Dec; 44():103800. PubMed ID: 37734562 [TBL] [Abstract][Full Text] [Related]
16. A review of photodynamic therapy in cutaneous leishmaniasis. van der Snoek EM; Robinson DJ; van Hellemond JJ; Neumann HA J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):918-22. PubMed ID: 18624853 [TBL] [Abstract][Full Text] [Related]
17. In Vivo Bioluminescent Monitoring of Parasites in BALB/c Mouse Models of Cutaneous Leishmaniasis Drug Discovery. Caridha D; Leed S; Cawlfield A Methods Mol Biol; 2020; 2081():81-106. PubMed ID: 31721120 [TBL] [Abstract][Full Text] [Related]